In a recent clinical study in which the expression and clinical impact of the WNT5A, WNT7B, FZD7 and GPC1 proteins were investigated in tumour samples, LUSC patients with no or minimal increase in WNT5A protein levels had the longest survival [20]. The gene discussed is WNT5A; the disease is neoplasm.